Filed Pursuant to Rule 424(b)(5)
Registration No. 333-272237
The information in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not
permitted.
SUBJECT TO
COMPLETION, DATED SEPTEMBER 4, 2024
PRELIMINARY PROSPECTUS SUPPLEMENT
(To Prospectus dated May 26, 2023)
$ % Fixed-to-Fixed Reset Rate
Junior Subordinated Notes due 20
We are offering $ aggregate principal amount of our % Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 20 (the notes). The notes will bear interest (i) from and including , 2024 (the original issue
date) to, but excluding, October 1, 2034 at the rate of % per annum and (ii) from and including October 1, 2034, during each Reset Period (as defined herein) at a rate per annum equal to the Five-year
U.S. Treasury Rate (as defined herein) as of the most recent Reset Interest Determination Date (as defined herein) plus a spread of %, to be reset on each Reset Date (as defined herein), and will mature on October 1,
20 . Interest on the notes will accrue from and including , 2024 and will be payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2025.
So long as no event of default (as defined herein) with respect to the notes has occurred and is continuing, we may, at our option, defer
interest payments on the notes, from time to time, for one or more deferral periods of up to 20 consecutive semi-annual Interest Payment Periods (as defined herein) each. During any deferral period, interest on the notes will continue to accrue at
the then-applicable interest rate on the notes (as reset from time to time on any Reset Date occurring during such deferral period in accordance with the terms of the notes) and, in addition, interest on deferred interest will accrue at the
then-applicable interest rate on the notes (as reset from time to time on any Reset Date occurring during such deferral period in accordance with the terms of the notes), compounded semi-annually, to the extent permitted by applicable law. See
Description of the NotesOption to Defer Interest Payments.
The notes will be issued in denominations of $2,000 and
integral multiples of $1,000 in excess thereof.
At our option, we may redeem notes at the times and at the applicable redemption prices
described in this prospectus supplement. The notes will be our unsecured obligations and will rank junior and subordinate in right of payment to the prior payment in full of our existing and future Senior Indebtedness (as defined herein). The notes
will rank equally in right of payment with our existing $1.0 billion aggregate principal amount of 4.125% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due
2052, $1.1 billion aggregate principal amount of 6.875% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2054, and $758 million aggregate principal
amount of 5.750% Junior Subordinated Notes due 2079 and with any future unsecured indebtedness that we may incur from time to time if the terms of such indebtedness provide that it ranks equally with the notes in right of payment.
The notes are a new issue of securities with no established trading market. We do not intend to apply for the listing or trading of the notes on
any securities exchange or trading facility or for inclusion of the notes in any automated quotation system.
Investing in
the notes involves risks. See the Risk Factors beginning on page S-12 of this prospectus supplement.
|
|
|
|
|
|
|
|
|
|
|
Per Note |
|
|
Total |
|
Public Offering Price(1) |
|
|
|
% |
|
$ |
|
|
Underwriting Discount |
|
|
|
% |
|
$ |
|
|
Proceeds to Sempra (before expenses)(1) |
|
|
|
% |
|
$ |
|
|
(1) |
Plus accrued interest from , 2024, if settlement occurs after that date.
|
Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of
these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the notes in book-entry form through the facilities of The Depository Trust Company for the accounts of its
participants, including Clearstream Banking S.A. and Euroclear Bank S.A./N.V., as operator of the Euroclear System, against payment in New York, New York on or about , 2024.
Joint Book-Running Managers
|
|
|
|
|
|
|
|
|
|
|
Barclays |
|
BMO Capital Markets |
|
CIBC Capital Markets |
|
Citigroup |
|
Santander |
|
Wells Fargo Securities |
, 2024